Page last updated: 2024-08-22

yttrium and Disease Exacerbation

yttrium has been researched along with Disease Exacerbation in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Castelli, E; Collura, D; Coverlizza, S; D'Urso, L; Demarchi, A; Giacobbe, A; Muto, G; Muto, GL	1
Benson, AB; Gates, VL; Habib, A; Hickey, R; Kircher, S; Lewandowski, RJ; Mulcahy, MF; Newman, S; Nimeiri, H; Salem, R; Vouche, M	1
Elseth, KM; Maker, VK; Radosevich, JA	1

Trials

1 trial(s) available for yttrium and Disease Exacerbation

Article	Year
Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization. International journal of radiation oncology, biology, physics, 2014, Apr-01, Volume: 88, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiation-Sensitizing Agents; Radiometry; Time Factors; Treatment Outcome; Yttrium	2014

Article

Year

Chemoradiation of hepatic malignancies: prospective, phase 1 study of full-dose capecitabine with escalating doses of yttrium-90 radioembolization.

International journal of radiation oncology, biology, physics, 2014, Apr-01, Volume: 88, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Capecitabine; Chemoradiotherapy; Cholangiocarcinoma; Deoxycytidine; Disease Progression; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiation-Sensitizing Agents; Radiometry; Time Factors; Treatment Outcome; Yttrium

2014

Other Studies

2 other study(ies) available for yttrium and Disease Exacerbation

Article	Year
Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology, 2014, Volume: 83, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aluminum; Cystectomy; Disease Progression; Endoscopy; Female; Follow-Up Studies; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Prospective Studies; Recurrence; Thulium; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Yttrium	2014
Reduced in vivo local recurrence with contact neodymium: Yttrium-Aluminium-Garnet (Nd:YAG) laser scalpels. Lasers in surgery and medicine, 1995, Volume: 17, Issue:4 Topics: Aluminum Silicates; Animals; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Laser Therapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neodymium; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm, Residual; Random Allocation; Survival Rate; Tumor Cells, Cultured; Yttrium	1995

Article

Year

Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages.

Urology, 2014, Volume: 83, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aluminum; Cystectomy; Disease Progression; Endoscopy; Female; Follow-Up Studies; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Prospective Studies; Recurrence; Thulium; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Yttrium

2014

Reduced in vivo local recurrence with contact neodymium: Yttrium-Aluminium-Garnet (Nd:YAG) laser scalpels.

Lasers in surgery and medicine, 1995, Volume: 17, Issue:4

Topics: Aluminum Silicates; Animals; Cohort Studies; Disease Progression; Disease-Free Survival; Female; Laser Therapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neodymium; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasm, Residual; Random Allocation; Survival Rate; Tumor Cells, Cultured; Yttrium

1995